AV, P., AA, S., SN, K., IV, K., LG, R., MI, S., . . . VB, N. (2022). Evaluation of the stability of furosemide in tablet form during six-month storage in spaceflight and peculiarities of its pharmacokinetics and pharmacodynamics under conditions of anti-orthostatic hypokinesia. Drug metabolism and personalized therapy, 37(3), 249. https://doi.org/10.1515/dmpt-2021-0149
Chicago Style (17th ed.) CitationAV, Polyakov, Svistunov AA, Kondratenko SN, Kovachevich IV, Repenkovа LG, Savelyevа MI, Shikh EV, and Noskov VB. "Evaluation of the Stability of Furosemide in Tablet Form During Six-month Storage in Spaceflight and Peculiarities of Its Pharmacokinetics and Pharmacodynamics Under Conditions of Anti-orthostatic Hypokinesia." Drug Metabolism and Personalized Therapy 37, no. 3 (2022): 249. https://doi.org/10.1515/dmpt-2021-0149.
MLA (9th ed.) CitationAV, Polyakov, et al. "Evaluation of the Stability of Furosemide in Tablet Form During Six-month Storage in Spaceflight and Peculiarities of Its Pharmacokinetics and Pharmacodynamics Under Conditions of Anti-orthostatic Hypokinesia." Drug Metabolism and Personalized Therapy, vol. 37, no. 3, 2022, p. 249, https://doi.org/10.1515/dmpt-2021-0149.